Compare PCLA & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCLA | SSKN |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 8.9M |
| IPO Year | 2025 | 2005 |
| Metric | PCLA | SSKN |
|---|---|---|
| Price | $5.06 | $0.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 41.6K | ★ 408.6K |
| Earning Date | 02-13-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,065,197.00 | ★ $30,980,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.26 | N/A |
| 52 Week Low | $3.46 | $0.28 |
| 52 Week High | $294.00 | $3.86 |
| Indicator | PCLA | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 63.77 | 19.51 |
| Support Level | $4.88 | $1.03 |
| Resistance Level | $5.95 | $1.32 |
| Average True Range (ATR) | 0.83 | 0.12 |
| MACD | -0.11 | -0.08 |
| Stochastic Oscillator | 14.29 | 6.07 |
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.